Drug Shortage Report for TEVA-MONTELUKAST

Last updated on 2022-10-18 History
Report ID 163951
Drug Identification Number 02355515
Brand name TEVA-MONTELUKAST
Common or Proper name TEVA-MONTELUKAST 5MG CHEW TABS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) MONTELUKAST
Strength(s) 5MG
Dosage form(s) TABLET (CHEWABLE)
Route of administration ORAL ORAL
Packaging size 30
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-06-30
Estimated end date 2022-10-20
Actual end date 2022-10-17
Shortage status Resolved
Updated date 2022-10-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2022-10-18 English Compare
v13 2022-10-17 French Compare
v12 2022-10-17 English Compare
v11 2022-09-30 French Compare
v10 2022-09-30 English Compare
v9 2022-09-22 French Compare
v8 2022-09-22 English Compare
v7 2022-08-18 French Compare
v6 2022-08-18 English Compare
v5 2022-08-15 French Compare
v4 2022-08-15 English Compare
v3 2022-07-01 English Compare
v2 2022-06-30 French Compare
v1 2022-06-30 English Compare

Showing 1 to 14 of 14